The “Breath Biopsy” Tested to Detect Malignant Mesothelioma by UK Scientists
Identifying malignant mesothelioma prior to diagnosis can be difficult – especially due to the amount of time it takes the diseases’ symptoms to become apparent. To better aid with detecting the asbestos-related disease, a UK-based medical manufacturer has announced the start of clinical trials for their new disease breathalyzer – the Owlstone’s Breath Biopsy®. In both Canada and the United States, the International Association of Heat and Frost Insulators and Allied Workers (IAHFIAW), whose members are knowingly at risk for the malignant mesothelioma, has partnered with the Cambridge based Owlstone Medical for such trials.
President of the Insulators Union, James McCourt, stated, “The population of those who have been exposed to asbestos and are at risk of having an existing early-stage disease or developing malignant mesothelioma later in their lives includes a substantial portion of our membership. The lon..Details